Lucid Diagnostics (LUCD) Free Cash Flow Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | Lucid Diagnostics | 145.00 Mn | 117.12 Mn | -325,000.00 | 1.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93% |
| Dec 31, 2025 | -24.82% |
| Sep 30, 2025 | -7.33% |
| Jun 30, 2025 | 7.91% |
| Mar 31, 2025 | 0.72% |
| Dec 31, 2024 | 0.24% |
| Sep 30, 2024 | -15.69% |
| Jun 30, 2024 | -65.16% |
| Mar 31, 2024 | -77.23% |
| Dec 31, 2023 | -127.62% |
| Sep 30, 2023 | -81.30% |
| Jun 30, 2023 | 54.73% |
| Mar 31, 2023 | -20.48% |
| Dec 31, 2022 | 58.31% |
| Sep 30, 2022 | -119.50% |
| Jun 30, 2022 | -569.15% |
| Mar 31, 2022 | -78.22% |
| Dec 31, 2021 | -538.49% |